title: High indinavir plasma concentrations in HIV-positive patients co-infected with hepatitis B or C virus treated with low doses of indinavir and ritonavir (400/100 mg twice a day) plus two nucleoside reverse transcriptase inhibitors.
authors.forename: Philippe
authors.initials: P
authors.lastname: Bossi
authors.forename: Gilles
authors.initials: G
authors.lastname: Peytavin
authors.forename: Claire
authors.initials: C
authors.lastname: Lamotte
authors.forename: Vincent
authors.initials: V
authors.lastname: Calvez
authors.forename: François
authors.initials: F
authors.lastname: Bricaire
authors.forename: Dominique
authors.initials: D
authors.lastname: Costagliola
authors.forename: Christine
authors.initials: C
authors.lastname: Katlama
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000150:complications*; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000008:administration & dosage* / Q000097:blood; D019694:Hepatitis B, Chronic / Q000150:complications*; D019698:Hepatitis C, Chronic / Q000150:complications*; D006801:Humans; D019469:Indinavir / Q000008:administration & dosage* / Q000097:blood; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage; D019438:Ritonavir / Q000008:administration & dosage
chemical_list: D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors; D019469:Indinavir; D019438:Ritonavir